Cargando…

Human aging : from cellular mechanisms to therapeutic strategies /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Carudo, Calogero (Editor ), Candore, Giuseppina (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: London, United Kingdom : Academic Press, 2021.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 SCIDIR_on1251803624
003 OCoLC
005 20231120010543.0
006 m o d
007 cr cnu---unuuu
008 210519s2021 enka o 001 0 eng d
040 |a OPELS  |b eng  |e rda  |e pn  |c OPELS  |d OCLCO  |d EBLCP  |d YDX  |d OCLCF  |d N$T  |d DKU  |d OCLCQ  |d COM  |d OCLCO  |d OCLCQ  |d OCLCO 
019 |a 1250601846 
020 |a 9780128227374  |q (electronic bk.) 
020 |a 0128227370  |q (electronic bk.) 
020 |z 9780128225691 
020 |z 0128225696 
035 |a (OCoLC)1251803624  |z (OCoLC)1250601846 
050 4 |a QP86 
082 0 4 |a 612.67  |2 23 
245 0 0 |a Human aging :  |b from cellular mechanisms to therapeutic strategies /  |c edited by Calogero Caruso and Giuseppina Candore. 
264 1 |a London, United Kingdom :  |b Academic Press,  |c 2021. 
300 |a 1 online resource (1 volume) :  |b illustrations (black and white, and color) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
500 |a Includes index. 
588 0 |a Print version record. 
505 0 |a Intro -- Human Aging: From Cellular Mechanisms to Therapeutic Strategies -- Copyright -- Contents -- Contributors -- About the editors -- Preface -- Chapter 1: Aging and longevity: An evolutionary approach -- 1.1. Introduction -- 1.2. Why does aging occur? -- 1.3. Mechanisms of aging -- 1.4. Causality and chance in aging and longevity -- 1.5. Conclusions and future perspectives -- References -- Chapter 2: Demographic aspects of aging -- 2.1. Introduction -- 2.2. Understanding the process: Browsing around the demographic transition theories -- 2.3. Aging inequalities 
505 8 |a 2.3.1. Differences by gender, education, and cause of death -- 2.3.2. Does having a longer life also mean having a better life? -- 2.3.3. Economics of population aging -- 2.4. Conclusions and perspectives -- References -- Chapter 3: Pathobiology of aging: An introduction to age-related diseases -- 3.1. Introduction -- 3.2. Complexity -- 3.3. Hallmarks of aging -- 3.4. Genomic instability -- 3.5. Epigenetic alteration -- 3.6. Deregulated nutrient sensing pathways -- 3.6.1. FOXO3 -- 3.6.2. Insulin/IGF-1 pathway -- 3.6.3. mTOR pathway -- 3.6.4. Sirtuin pathway -- 3.6.5. Autophagy 
505 8 |a 3.7. Loss of proteostasis -- 3.8. Mitochondrial dysfunction -- 3.9. Telomere attrition -- 3.10. Cellular senescence -- 3.11. Stem cell exhaustion -- 3.12. Altered intercellular communication -- 3.13. Cancer and aging -- 3.14. Conclusion and future perspectives -- References -- Chapter 4: Cellular senescence and senescence-associated secretory phenotype (SASP) in aging process -- 4.1. Introduction -- 4.2. Signaling pathway stimulating the appearance of SASP -- 4.3. SASP components -- 4.4. MiRNA and extracellular vesicles as new regulators and components of SASP 
505 8 |a 4.5. SASP profile in different cell types -- 4.6. Cellular senescence, SASP, and aging -- 4.7. Conclusions and future perspectives -- References -- Chapter 5: The role of inflammaging in the development of chronic diseases of older people -- 5.1. Introduction -- 5.2. Basic mechanisms: Cellular senescence, inflammaging, molecular inflammation, and senoinflammation -- 5.2.1. Cellular senescence -- 5.2.2. Inflammaging -- 5.2.3. Molecular inflammation -- 5.2.4. Senoinflammation -- 5.3. Is chronic inflammatory state a common denominator of ARDs? -- 5.3.1. T2DM 
505 8 |a 5.3.2. Chronic aging-related respiratory diseases -- 5.3.3. Atherosclerosis -- 5.3.4. Frailty -- 5.3.5. Alzheimer's disease (AD) -- 5.3.6. Parkinson's disease (PD) -- 5.4. The case of COVID-19 -- 5.5. Proposed interventions to prevent ARDs -- 5.6. Conclusion and future perspective -- References -- Chapter 6: A new perspective on ROS in aging with an integrated view of the gut microbiota -- 6.1. Introduction -- 6.2. The reactive oxygen species -- 6.3. The biological function of ROS -- 6.4. The oxidative stress theory of aging 
650 0 |a Aging. 
650 0 |a Age factors in disease. 
650 2 |a Aging  |0 (DNLM)D000375 
650 2 |a Age Factors  |0 (DNLM)D000367 
650 6 |a Vieillissement.  |0 (CaQQLa)201-0020292 
650 6 |a Maladies  |x Facteurs li�es �a l'�age.  |0 (CaQQLa)201-0000226 
650 7 |a Age factors in disease  |2 fast  |0 (OCoLC)fst00800172 
650 7 |a Aging  |2 fast  |0 (OCoLC)fst00800293 
700 1 |a Carudo, Calogero,  |e editor. 
700 1 |a Candore, Giuseppina,  |e editor. 
776 0 8 |i Print version:  |t HUMAN AGING.  |d [Place of publication not identified] : ELSEVIER ACADEMIC PRESS, 2021  |z 0128225696  |w (OCoLC)1190853212 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/book/9780128225691  |z Texto completo